English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Dear Editor, P olypoidal choroidal vasculopathy (PCV) was first described by Yannuzzi [1] in the 1980s as a distinct choroidal abnormality. Clinically, PCV is seen as orange-red subretinal nodules [2] frequently presenting with submacular haemorrhage or serosanguinous pigment epithelial detachments (PED) . Indocyanine green angiography (ICGA) provides the means to confirm the diagnosis of PCV, with angiographic features of early focal hyperfluorescence (within 6min of angiography), with or without associated branching vascular networks. Formal PCV definitions were first proposed by the Japanese Study Group of Polypoidal Choroidal Vasculopathy, which suggested a diagnosis of "definite" PCV in the presence of protruding elevated orange-red lesions on fundus examination and/or characteristic polypoidal lesions on ICGA. A diagnosis of "probable" PCV was made if only the abnormal branching vascular network was seen on ICGA and/or presence of recurrent hemorrhagic and/or serous detachment of the retinal pigment epithelium (RPE)[4]. More recently, the EVEREST trial defined PCV as presence of early (within 6min of dye injection) subretinal focal ICGA hyperfluorescence, plus at least one of the following angiographic or clinical criteria: association with a branching vascular network, presence of pulsatile polyp, nodular appearance when viewed stereoscopically, presence of hypofluorescent halo (in the first 6min of angiography), orange subretinal nodule on colour fundus photograph or association with massive submacular hemorrhage (at least 4 disc areas). In this report, we describe three cases that met the EVEREST trial definition of PCV, as well as the Japanese Study Group's definition of "definite" PCV. However, they appear to be a unique subset of PCV as they presented with very large non-pulsatile polyps with an apparent internal architecture. The cases were also more resistant to treatment. To our knowledge, this distinctive phenotypic subset of PCV has not been described before. Report of Cases A 64 year-old Chinese male presented with right poor vision of uncertain duration. He was a smoker and had hypertension, hyperlipidemia, and a history of a previous cerebrovascular accident. His right best corrected visual acuity (BCVA) on presentation was counting fingers at half metre. In the right fundus, there was an orange-red nodule associated with a half disc diameter haemorrhagic PED at the macula with surrounding subretinal fluid (SRF) and hard exudates (Figure 1). Right eye ICGA revealed a large polyp measuring 1381 滋m (in the largest diameter). It was nodular stereoscopically, non-pulsatile, with no associated branching vascular networks (BVN). There was presence of a hypofluorescent halo around the polyp, and the polyp appeared to have an intraluminal architecture. Optical coherence tomography (OCT) showed a peaked sub-RPE lesion with SRF in the right eye. The patient declined anti-vascular endothelial growth factor (VEGF) injections in view of his vascular risk factors and opted for photodynamic therapy (PDT). He underwent 2 PDT treatments with no sustained improvement. His most recent BCVA is counting fingers closely in the right eye. Case 2 A 55 year-old Chinese gentleman presented with right poor vision for a month. He had hypertension and was a smoker. His right BCVA on presentation was 20/80. In the right fundus, there was an orange-red nodule seen with subretinal haemorrhage and surrounding SRF (Figure 2). Right ICGA revealed a large polyp measuring 1388 滋m (in the largest diameter). It was nodular stereoscopically, non-pulsatile, with no associated BVN. There was presence of a hypofluorescent halo around the polyp, and the polyp appeared to have an intraluminal architecture. OCT showed a peaked sub-RPE lesion with SRF. The patient underwent 11 intravitreal ranibizumab injections. However, the SRF persisted and his most recent BCVA is 20/50. Case 3 A 60 year-old Chinese gentleman presented with right blurred vision for 3mo. He was a smoker with hypertension, hyperlipidemia and ischaemic heart disease. His right BCVA on presentation was 20/40. In the right fundus, there were two orange-red nodules seen with PEDs at the macula (Figure 3). Giant non-pulsatile polypoidal choroidal vasculopathy 窑Letter to the Editor窑